INTERVIEW: Scripps Research dealmaker talks shop
This article was originally published in Scrip
Executive Summary
A five-year agreement between the Scripps Research Institute (TSRI) and Janssen Pharmaceuticals to collaborate on infectious disease research reflects a new approach to deal-making that supports the labs at San Diego-based Scripps, where scientists are trained to "eat what they kill" in terms of public and private funding.